Specialty & Oncology November 2018

CAR-T Cells: Driving a New Era of Oncology Immunotherapy

The innovation of CD19-directed chimeric antigen receptor T cells has paved the way for a novel therapeutic approach to the management of some relapsed and refractory B-cell leukemias and lymphomas.

Management of Bleeding in Patients Treated With Direct Oral Anticoagulants

With no need for frequent blood monitoring and fewer drug and dietary interactions, DOACs present advantages over vitamin K antagonists.

Why We Need Standardized Performance Measures in Specialty Practice

Specialty pharmacies should look to endorsed quality measures that provide a consistent and standard evaluation of performance.

Continuing Education

$6.97 Per CE Exam or $59 for 12 Lessons